With more than twenty years of experience behind us, over time we have become a reference point in health and safety, and privileged interlocutors for hospitals, healthcare facilities and multinationals in this sector.
"It's not the tragedies that define our lives, but the choices we make to face them"Arrow up
Viadana, September 20th, 2017
Delta Med S.p.A. (Delta Med) and Alfamed S.r.l. (Alfamed) are pleased to announce the signing of a definitive agreement for the acquisition of the critical care branch of Alfamed by Delta Med.
Augens Capital, Delta Med S.p.A. (Delta Med) and Tipromed S.r.l. (Tipromed) are pleased to announce the signing of the definitive agreement for the acquisition of 100% of the capital of Tipromed by Delta Med
Tipromed S.r.l. is a company operating in the field of peripheral safety catheters with "closed system" with a turnover of 2016 estimated at €2.0 million. Tipromed is controlled by three partners, two of whom are founders, Emanuele Minari and Franco Petrali, who each own 45%. Minali and Petrali are renowned operators and experts in the world of peripheral vascular accesses, having been among the founders of Delta Med itself.
Tipromed was founded in 2010 on the intuition that the vascular accesses market needed a sophisticated product with some innovative features. Leveraging their technical capabilities, Minari and Petrali have progressively acquired market shares in Italy and are beginning their international development. A significant increase in turnover is also expected through international distribution agreements.
Tipromed therefore represents an excellent strategic opportunity for Delta Med for the very high complementarity of its product range. Among other things, Tipromed and Delta Med already have a commercial relationship in place as Delta Med distributes the Tipromed product in some Italian regions and in some international countries, including North America.
As part of the operation, Mr. Petrali and Mr. Minari will continue to manage Tipromed, reporting to the Board of Directors appointed by Delta Med. They will also become shareholders of Delta Med.
The acquisition was entirely financed by an acquisition financing line provided by MPS Capital Services. In the transaction Delta Med was assisted by the law firm LMS and EY for the accounting and fiscal due diligence.
Augens Capital is an investment company established in 2014 to make investments in medium-sized Italian companies with a particular focus on family businesses with issues of generational transition, orphan companies, situations that present opportunities for consolidation of the sector and companies that need capital and skills to pursue expansion in international markets.